Cercar
05/03/2025
Heterogeneity of cognitive progression and clinical predictors in Parkinson's disease-subjective cognitive decline
Rodríguez-Antigüedad, J, Martinez-Horta, S, Puig-Davi, A, Horta-Barba, A, Pagonabarraga, J, Fonticoba, TD, Jesús, S, Cosgaya, M, Caldentey, JG, avila-Rivera, MA, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Mayordomo, VG, Ardura, JG, Garcia-Soto, JD, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Mendoza, Z, Parees, I, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Martinez, JR, Buongiorno, MT, Ordas, C, Valero, C, Puente, V, Kurtis, M, Estrada, MB, Martínez-Martín, P, Mir, P, Santos-García, D, Kulisevsky, J. Heterogeneity of cognitive progression and clinical predictors in Parkinson's disease-subjective cognitive decline. JOURNAL OF NEUROLOGY. 2025; 272(3)DOI:10.1007/s00415-024-12808-0. PMID:40042541. IF:4.600(Q1/2D).
08/01/2026
Pain Hypersensitivity in a Mouse Model of Marfan Syndrome
Kordikowski, R, Coutinho, J, Martínez-Martel, I, Penas, C, Martín-Mur, B, Pérez, B, Jiménez-Altayó, F, Pol, O. Pain Hypersensitivity in a Mouse Model of Marfan Syndrome. Antioxidants. 2026; 15(1)DOI:10.3390/antiox15010080. PMID:41596139. IF:6.600(Q1/1D).
18/12/2025
Hydrogen-Rich Water Potentiates Cannabinoid- and Gabapentinoid-Induced Analgesia in Neuropathic Pain
Tort, NA, Negrini-Ferrari, SE, Pol, O. Hydrogen-Rich Water Potentiates Cannabinoid- and Gabapentinoid-Induced Analgesia in Neuropathic Pain. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(24)DOI:10.3390/ijms262412155. PMID:41465581. IF:4.900(Q1/3D).
01/06/2025
Fast-track strategy to shorten hospital stay in acute complicated paediatric appendicitis: protocol of the FTAA clinical trial
Leganes, C, Zapata, MJM, Valle, JM, Membrilla, E, Bordon, EA, Palazón, P, Fortes, LM, Núñez, B, Alvarez, N, Pueyo, C, Soria, A, Oviedo, M, Delgado-Espinoza, CE, Antonijoan, RM. Fast-track strategy to shorten hospital stay in acute complicated paediatric appendicitis: protocol of the FTAA clinical trial. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).
01/06/2025
Non-commercial sponsored clinical trials with medicinal products in Spain since CTIS implementation
Delgado-Espinoza, CE, Garcia, CP, Hosey, KA, Pestana, MJC, Lasso, LFC, Arbos, RMA. Non-commercial sponsored clinical trials with medicinal products in Spain since CTIS implementation. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).
01/06/2025
Environmental impact of avoidable tertiary care: earth-caring arguments for decentralizing trials
Pontes, C, Cortes, M, Delgado, CE, Castillo, LF, Amaro, K, Torres, F, Antonijoan, RM. Environmental impact of avoidable tertiary care: earth-caring arguments for decentralizing trials. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).
01/06/2025
Needle in the haystack: searching for relevance in systematic screening of adverse drug reactions
Pestana, MC, Lasso, LFC, Hosey, KCA, Espinoza, CED, Garcia, CP, Arbos, RMA. Needle in the haystack: searching for relevance in systematic screening of adverse drug reactions. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).
01/06/2025
Increasing use of gabapentinoids out of their authorised indications
Pontes, C, Cortés, M, de Pando, T, Gomez-Oliveros, B, Antonijoan, RM, Carot-Sans, G, Ramiro, M. Increasing use of gabapentinoids out of their authorised indications. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2025; 81(1)DOI:. PMID:. IF:2.700(Q2/5D).